BYU TECHNOLOGIES AVAILABLE FOR LICENSE
View our List of Promising Technologies (pdf)
Technologies
Nano propellant based upon micro-encapsulation of Energetic Anions in the Biological Modecule Ferritin
ID: 2009-70 Nano propellant based upon micro-encapsulation of Energetic Anions in the Biological Modecule Ferritin
Technologies
Nano Propellants based upon Aluminum-Hydrogen Peroxide Ferritin
ID: 2009-69 Nano Propellants based upon Aluminum-Hydrogen Peroxide Ferritin
Technologies
Natural product biflavinoid inhibitors of tryptase for treatment of inflammation
ID: 2018-059 Natural product biflavinoid inhibitors of tryptase for treatment of inflammation
Navigating iEdison Compliance: Practical Tips for Tech Transfer Offices
In this episode, BYU Tech Transfer Director Dave Brown and tech transfer consultant Colleen Kohler offer a detailed guide to iEdison compliance, especially for professionals managing federally funded inventions. Colleen shares actionable tips for tackling utilization reports and understanding recent updates to the iEdison system. With insights on federal requirements, managing timelines, and handling licensing complexities, they simplify the process of filing accurate reports. This episode is invaluable for tech transfer professionals and administrators responsible for university compliance, helping them streamline iEdison reporting while avoiding common pitfalls.
Navigating Patent Challenges in Tech Transfer: Top 5 Issues Universities Face
In this podcast episode, BYU Tech Transfer Director David Brown and patent attorney Adam Stevens explore the top five patent challenges faced by universities and inventors in the tech transfer process. They discuss crucial topics such as:
Technologies
Near Constant Force Electrical Contact
ID: 2000-28
A method and apparatus for delivering a substantially constant reaction force in response to an applied displacement, regardless of the magnitude or change of the displacement.
Technologies
Nelfinavir Treatment of MCF-7 Breast Cancer Cells Lowers Hepcidin, Increases Ferroportin, Decreases Cellular Iron and Lowers Cell Viability: Hope to Increase Survival of Breast Cancer Patients
ID: 2022-029 Nelfinavir Treatment of MCF-7 Breast Cancer Cells Lowers Hepcidin, Increases Ferroportin, Decreases Cellular Iron and Lowers Cell Viability: Hope to Increase Survival of Breast Cancer Patients